title: The anticancer effect of PQ1 in the MMTV-PyVT mouse model.
abstract: Animal models are commonly used to analyze the mechanism of carcinogenesis as well as the development and screening of potent drugs. Here the transgenic strain FVB/N-Tg(MMTV-PyVT)634Mul/J (also known as PyVT) was used as a model system for measuring tumor burden, drug sensitivity, and metastasis of mammary carcinomas. Loss of gap junctional intercellular communication and the down regulation of connexin expression are characteristic of neoplastic cells. The substituted quinoline, 6-methoxy-8-[(3-aminopropyl)amino]-4-methyl-5-(3-trifluoromethyl-phenyloxy)quinolone (PQ1), has been shown to restore GJIC and increase connexin expression in breast cancer cell lines while not affecting normal mammary cells, suggesting that it may provide effective anticancer treatment with less detrimental effects. The PyVT spontaneous mammary tumor mouse model was used to determine the biological and histological effects of PQ1 on tumorigenesis and metastasis at three stages of development: Pretumor, early tumor and late tumor formation. Treatment with PQ1 at all three stages of development significantly reduced tumor growth. PQ1 treatment further increased Cx43 expression during pre- and early-tumor formation, while it prevented an increase in Cx46 expression during late stage tumor formation. This study shows that Cx43 expression and neoplastic cellular growth are inversely related, but that PQ1 can alter tumor growth through targeting gap junction proteins to prove clinical efficacy in the treatment of spontaneous mammary tumors.
authors.affiliation: Department of Diagnostic Medicine and Pathobiology, Kansas State University, Manhattan, KS.
authors.forename: Stephanie N
authors.initials: SN
authors.lastname: Shishido
authors.forename: Adélaïde
authors.initials: A
authors.lastname: Delahaye
authors.forename: Amanda
authors.initials: A
authors.lastname: Beck
authors.forename: Thu Annelise
authors.initials: TA
authors.lastname: Nguyen
mesh_terms: D000634:Aminoquinolines / Q000627:therapeutic use*; D000818:Animals; D015153:Blotting, Western; D049109:Cell Proliferation; D018031:Connexin 43 / Q000235:genetics / Q000378:metabolism; D004195:Disease Models, Animal; D005260:Female; D017629:Gap Junctions / Q000187:drug effects* / Q000235:genetics / Q000378:metabolism; D006801:Humans; D007124:Immunoenzyme Techniques; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D008324:Mammary Tumor Virus, Mouse / Q000235:genetics*; D051379:Mice; D008822:Mice, Transgenic
chemical_list: D000634:Aminoquinolines; D018031:Connexin 43; C577576:PQ1 compound
keywords: MMTV-PyVT; PQ1; connexin; gap junctions
references.citation: Biochim Biophys Acta. 2005 Dec 20;1719(1-2):125-45
references.pmid: 16359943
references.citation: Exp Eye Res. 2011 Apr;92(4):251-9
references.pmid: 21320488
references.citation: Anticancer Drugs. 2012 Oct;23(9):897-905
references.pmid: 22569107
references.citation: Nat Rev Cancer. 2003 Jan;3(1):46-54
references.pmid: 12509766
references.citation: Cancer Res. 2001 Nov 15;61(22):8298-305
references.pmid: 11719463
references.citation: Nucleic Acids Res. 1984 May 25;12(10):4191-206
references.pmid: 6328415
references.citation: N Engl J Med. 1999 Aug 5;341(6):452-3
references.pmid: 10438269
references.citation: Cell Tissue Res. 2010 May;340(2):229-42
references.pmid: 20336469
references.citation: Clin Cancer Res. 2000 Jan;6(1):127-34
references.pmid: 10656440
references.citation: J Cell Biol. 1991 Dec;115(5):1357-74
references.pmid: 1659577
references.citation: Br J Cancer. 1993 Sep;68(3):579-83
references.pmid: 8394732
references.citation: Pflugers Arch. 2008 Jun;456(3):519-27
references.pmid: 18172602
references.citation: Bioorg Med Chem Lett. 2008 Jun 1;18(11):3364-8
references.pmid: 18457950
references.citation: J Cell Biochem. 2003 Jun 1;89(3):450-61
references.pmid: 12761879
references.citation: J Clin Invest. 2004 Oct;114(8):1117-27
references.pmid: 15489959
references.citation: Am J Pathol. 1991 Apr;138(4):867-73
references.pmid: 2012175
references.citation: Biol Cell. 2002 Nov;94(7-8):493-500
references.pmid: 12566222
references.citation: Cell Growth Differ. 1996 Jul;7(7):861-70
references.pmid: 8809403
references.citation: Proc Natl Acad Sci U S A. 1992 Nov 1;89(21):10218-21
references.pmid: 1332037
references.citation: Cell Mol Life Sci. 2002 Aug;59(8):1406-12
references.pmid: 12363043
references.citation: Cancer Lett. 1987 Aug;36(2):161-8
references.pmid: 3621148
references.citation: Int J Cancer. 2010 Aug 15;127(4):839-48
references.pmid: 20013805
references.citation: Am J Pathol. 2003 Nov;163(5):2113-26
references.pmid: 14578209
references.citation: Biochim Biophys Acta. 2004 Mar 23;1662(1-2):42-60
references.pmid: 15033578
references.citation: J Biol Chem. 2011 May 13;286(19):16914-28
references.pmid: 21454606
references.citation: Ann Clin Lab Sci. 1994 May-Jun;24(3):216-31
references.pmid: 8048793
references.citation: Biochim Biophys Acta. 2004 Mar 23;1662(1-2):61-80
references.pmid: 15033579
references.citation: Oncogene. 1996 Dec 19;13(12):2507-15
references.pmid: 9000125
references.citation: Cell Signal. 2007 May;19(5):958-67
references.pmid: 17210245
references.citation: Nature. 1966 Mar 19;209(5029):1248-9
references.pmid: 5956321
references.citation: J Cell Biol. 1967 May;33(2):225-34
references.pmid: 6039367
references.citation: Cancer Res. 2001 Mar 1;61(5):1765-7
references.pmid: 11280719
references.citation: Mol Cell Biol. 1992 Mar;12(3):954-61
references.pmid: 1312220
references.citation: Int J Biochem Cell Biol. 2004 Jul;36(7):1171-86
references.pmid: 15109565
references.citation: Biochem Biophys Res Commun. 1979 Nov 28;91(2):395-401
references.pmid: 518638
references.citation: Biochim Biophys Acta. 1979 Feb 4;560(1):1-65
references.pmid: 216404
references.citation: Anticancer Res. 2010 Oct;30(10):3927-32
references.pmid: 21036704
references.citation: Nat Med. 1997 Aug;3(8):917-21
references.pmid: 9256286
references.citation: Am J Pathol. 1998 Jan;152(1):43-9
references.pmid: 9422522
references.citation: Mol Biotechnol. 2005 Feb;29(2):153-63
references.pmid: 15699570
references.citation: PLoS One. 2012;7(9):e44963
references.pmid: 23028705
references.citation: Int J Oncol. 2002 Aug;21(2):315-20
references.pmid: 12118327